Exam 1 Flashcards
Chlorthalidone
Thiazide diuretic, antiHTN, and heart failure med. MOA: inhibits Na/Cl cotransporter in the distal convoluted tubule, causing Na,Cl, K, and water excretion (retains Ca). lowers peripheral resistance
Hydrochlorothiazide (HCTZ)
Thiazide diuretic, antiHTN, and heart failure med. MOA: inhibits Na/Cl cotransporter in the distal convoluted tubule, causing Na,Cl, K, and water excretion (retains Ca). lowers peripheral resistance
Indapamide
Thiazide diuretic, antiHTN, and heart failure med. MOA: inhibits Na/Cl cotransporter in the distal convoluted tubule, causing Na,Cl, K, and water excretion (retains Ca). lowers peripheral resistance
Metolazone
Thiazide diuretic, antiHTN, and heart failure med. MOA: inhibits Na/Cl cotransporter in the distal convoluted tubule, causing Na,Cl, K, and water excretion (retains Ca). lowers peripheral resistance
Bumetanide
Loop Diuretic, antiHTN, and heart failure med.MOA: Inhibits Na/K/2Cl cotransporter in ascending loop of Henle, causing Na, K, Ca, and water excretion. lowers peripheral resistance. Treats acute pulmonary edema of heart failure, hypercalcemia and hyperkalemia. AE: Ototoxicity, Hyperuricemia (causes gout), acute hypovolemia, hypomagnesemia. NET CHANGE: excrete Na+, K+, Ca++, urine
Ethacrynic acid
Loop Diuretic, antiHTN, and heart failure med.MOA: Inhibits Na/K/2Cl cotransporter in ascending loop of Henle, causing Na, K, Ca, and water excretion. lowers peripheral resistance. Treats acute pulmonary edema of heart failure, hypercalcemia and hyperkalemia. AE: Ototoxicity, Hyperuricemia (causes gout), acute hypovolemia, hypomagnesemia. NET CHANGE: excrete Na+, K+, Ca++, urine
Furosemide (Lasix)
Loop Diuretic, antiHTN, and heart failure med.MOA: Inhibits Na/K/2Cl cotransporter in ascending loop of Henle, causing Na, K, Ca, and water excretion. lowers peripheral resistance. Treats acute pulmonary edema of heart failure, hypercalcemia and hyperkalemia. AE: Ototoxicity, Hyperuricemia (causes gout), acute hypovolemia, hypomagnesemia. NET CHANGE: excrete Na+, K+, Ca++, urine
Torsemide
Loop Diuretic, antiHTN, and heart failure med.MOA: Inhibits Na/K/2Cl cotransporter in ascending loop of Henle, causing Na, K, Ca, and water excretion. lowers peripheral resistance. Treats acute pulmonary edema of heart failure, hypercalcemia and hyperkalemia. AE: Ototoxicity, Hyperuricemia (causes gout), acute hypovolemia, hypomagnesemia. NET CHANGE: excrete Na+, K+, Ca++, urine
Eplerenone (Inspra)
“Potassium-Sparing” Diuretic, antiHTN, (also for heart failure). MOA: inhibits aldosterone receptors in collecting tubule, causing Na/water excretion (retains K/H). lowers peripheral resistance; relieves edema and cardiac workload. PHARMACOKINETICS: Metabolized by P450 system into active metabolite, Highly bound to plasma proteins. AE: gynecomastia (in men), menstrual irregularities. NET CHANGE: excrete Na, urine. Retain K
Spironolactone (Aldactone)
“Potassium-Sparing” Diuretic, antiHTN, (also for heart failure). MOA: inhibits aldosterone receptors in collecting tubule, causing Na/water excretion (retains K/H). lowers peripheral resistance; relieves edema and cardiac workload. PHARMACOKINETICS: Metabolized by P450 system into active metabolite, Highly bound to plasma proteins. AE: gynecomastia (in men), menstrual irregularities. NET CHANGE: excrete Na, urine. Retain K. UNIQUE: used for advanced HF
Clonidine
Centrally acting alpha-2 agonist (for HTN). MOA: Lowers CO. UNIQUE Used when 2 or more HTN drugs have failed. Food for renal disease. AE: all mild: sedation, dry mouth, constipation, rebound hypertension, peripheral edema
Methyldopa
Centrally acting alpha-2 agonist (for HTN). MOA: Lowers CO. UNIQUE: can be used in pregnancy, AE: Drowsiness, peripheral edema
Doxazosin
Alpha blocker (for HTN). MOA: Relaxes arterial and venous smooth muscle. Rarely used by itself because of tolerance. can cause peripheral edema
Prazosin (Minipress)
Alpha blocker (for HTN). MOA: Relaxes arterial and venous smooth muscle. Rarely used by itself because of tolerance. can cause peripheral edema
Terazosin (Hytrin)
Alpha blocker (for HTN). MOA: Relaxes arterial and venous smooth muscle. Rarely used by itself because of tolerance. can cause peripheral edema
Acebutolol
Beta 1 blocker (for HTN and angina). MOA: Decreases CO and renin and increases NO production causing vasodilation. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Atenolol
Beta 1 blocker (for HTN and angina). MOA: Decreases CO and renin and increases NO production causing vasodilation. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death! UNIQUE: preferred in angina treatment
Bisoprolol
Beta 1 blocker (for HTN and angina). MOA: Decreases CO and renin and increases NO production causing vasodilation. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Esmolol
Beta 1 blocker (for HTN and angina) and Class II antiarrhythmic. MOA: Decreases CO and renin and increases NO production causing vasodilation. MOA 2:Inhibits phase 4 depolarization in SA and AV nodes. IV emergency arrhythmias AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Metoprolol
Beta 1 blocker, Class II Antiarrhythmic (for HTN, angina AND heart failure). Decreases CO and renin and increases NO production causing vasodilation. This reduces negative effects of heart remodeling. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death! MOA 2: Inhibits phase 4 depolarization in SA and AV nodes. most common beta blocker for arrhythmias. UNIQUE: preferred in angina treatment…. good for atrial flutter, atrial fibrillation
Nebivolol*
Beta 1 blocker (for HTN, angina AND heart failure). Decreases CO and renin and increases NO production causing vasodilation. This reduces negative effects of heart remodeling. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Carvedilol
AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!non-selective beta blocker (for HTN, angina, AND heart failure). MOA: Decreases CO and renin. This reduces negative effects of heart remodeling. Not for asthmatics!
Nadolol
non-selective beta blocker (for HTN, angina, AND heart failure). MOA: Decreases CO and renin. This reduces negative effects of heart remodeling. Not for asthmatics! AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Propranolol
non-selective beta blocker (for HTN, angina) and Class II antiarrhythmic. MOA: Decreases CO and renin. Not for asthmatics! MOA 2: Inhibits phase 4 depolarization in SA and AV nodes. Reduces sudden arrhythmic death after MI. AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Labetalol
non-selective beta blocker (for HTN, angina). MOA: Decreases CO and renin. Not for asthmatics! AE: Bradycardia, fatigue, decreased libido, sudden cessation can cause angina, MI, or death!
Amlodipine (Norvasc)
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. can cause peripheral edema. UNIQUE: has a long half life
Clevidipine
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. can cause peripheral edema. Short half life
Diltiazem
Calcium channel blocker (vasodilator for HTN and Angina). and Class IV Antiarrhythmic. MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema. UNIQUE: favorable side effect profile. MOA 2: Inhibits AP in SA and AV nodes in phase 4 to prevent spontaneous depolarization, prolongs refractory period. UNIQUE: contraindicated depressed cardiac function. good for atrial fibrillation and acute supraventricular tachycardia
Felodipine
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema
Isradipine
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema.
Nicardipine
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. can cause peripheral edema. UNIQUE: long half life, tx hypertensive emergency.
Nifedipine (Procardia)
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema.
Nisoldipine
Calcium channel blocker (vasodilator for HTN and Angina). MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema.
Verapamil
Calcium channel blocker (vasodilator for HTN and Angina). And Class IV Antiarrhythmic. MOA: Dilates arteries by blocking inward Ca to prevent muscle contraction. Has natural diuretic effect. Short half life. can cause peripheral edema. UNIQUE: Least selective calcium channel blocker….. MOA 2: Inhibits AP in SA and AV nodes in phase 4 to prevent spontaneous depolarization, prolongs refractory period. UNIQUE: contraindicated depressed cardiac function. Good for atrial flutter and AV Nodal reentry
Hydralazine
Vasodilator (for HTN and heart failure). MOA: Increases NO. can cause reflex heart stim, causing problems. pregnant ok!
Minoxidil
Vasodilator (for HTN). MOA: opens K channels that hypopolarize smooth muscle. can cause reflex heart stim, causing problems. Used topically to treat baldness
Fenoldopam
Parenteral agent (Vasodilator for HTN). MOA: Peripheral dopamine-1 receptor agonist to increase renal blood flow. increases IOP–avoid in glaucoma, send note to ER
Nitroprusside (Nitropress)
Parenteral agent (Vasodilator for HTN and heart failure). UNIQUE: MoA: increases cGMP, > NO increases to cause rapid vasodilation. very short half life. Poisonous if taken orally (converts to cyanide)
Benazepril (Lotensin)
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Captopril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Cilazapril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Enalapril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Fosinopril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Lisinopril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Moexipril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Perindopril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Quinapril (Accupril)
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Ramipril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Trandolapril
ACE inhibitor (for HTN and heart failure). MOA: Decreases angiotensin II and increases bradykinin, reducing water retention. AE: dry cough. hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Azilsartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Candesartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Eprosartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Irbesartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Losartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Olmesartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Telmisartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Valsartan
Angiotensin-2-receptor blockers (for HTN and heart failure) MOA: Reduces water retention; decreased preload and afterload for increased CO. AE: hyperkalemia when used with K-sparing diuretics, rash, fever, Fetotoxic
Aliskiren
Renin inhibitor (for HTN), MOA: decreases blood volume. metabolized by p450 system. AE: Cough (not like ace inhibitors, though), hyperkalemia. NOT for pregnancy
Acetazolamide (Diamox)
Carbonic Anhydrase Inhibitors (diuretic). MOA: CAI affects proximal convoluted tubule, TREATS glaucoma, mountain sickness. AE: metabolic acidosis, renal stones, drowsiness, paresthesia. NET CHANGE: excrete Na, K, HCO3- (bicarb), urine. UNIQUE systemic dose is good for angle closure (and glaucoma)
Methazolamide
Carbonic Anhydrase Inhibitors (diuretic). MOA: CAI affects proximal convoluted tubule, TREATS glaucoma, mountain sickness. AE: metabolic acidosis, renal stones, drowsiness, paresthesia. NET CHANGE: excrete Na, K, HCO3- (bicarb), urine.
Mannitol (Osmitrol)
Osmotic diuretic. MOA Carries water with it as it filters through glomerulus. used to prevent acute renal failure and in treatment of increased intracranial pressure.
Ranolazine (Ranexa)
Sodium channel blocker (for angina). MOA: Inhibits late phase of Na current to improve diastolic function. used for chroinic angina
Isosorbide dinitrate (Dilatrate-SR, Isordil)
Organic Nitrate (for angina and heart failure). MOA: Increases NO and cGMP (both for dilation). rapid onset, liver inactivates drug so it’s given sublingual or patch. AE: tachycardia, orthostatic hypertension, HA from brain vasodilation, tollerance requires “nitrate-free interval”
Isosorbide mononitrate (Imdur, Ismo)
Organic Nitrate (for angina) MOA: Increases NO and cGMP (both for dilation). rapid onset, liver inactivates drug so it’s given sublingual or patch. AE: tachycardia, orthostatic hypertension, HA from brain vasodilation, tollerance requires “nitrate-free interval”
Nitroglycerin
Organic Nitrate (for angina) MOA: Increases NO and cGMP (both for dilation). rapid onset, liver inactivates drug so it’s given sublingual or patch. AE: tachycardia, orthostatic hypertension, HA from brain vasodilation, tollerance requires “nitrate-free interval” UNIQUE: Tx classic angina
Digoxin
Inotrope (for heart failure) and antiarrhythmic. MOA: increases Ca by inhibiting Na/K pump, increase CO reduces heart rate. PHARMACOKINETICS: long half-life,narrow therapeutic index, never used alone, accumulates in muscle. Use ACE inhibitors/diuretics before Digoxin. AE: arrhythmia, toxicity especially with from decreased K levels. HA, fatigue, blurred vision, altered color, halos. MOA 2: shortens refractory period in myocardial cells and prolongs refractory period in AV node. good for atrial flutter, atrial fibrillation, and AV nodal rentry
Inamrinone
Inotrope (for heart failure). MOA: this phosphodiesterase inhibitor causes increase of cAMP, increases Ca. Long-term use increases mortality, so it’s short term via IV
Milrinone
Inotrope (for heart failure). MOA: this phosphodiesterase inhibitor causes increase of cAMP, increases Ca. Long-term use increases mortality, so it’s short term via IV
Dobutamine
Beta agonist (for heart failure). MOA: Increases contraction of heart increased protein kinase increases Ca influx. AE: risk of angina or arrhythmias
Dopamine
Beta agonist (for heart failure). MOA: Increases contraction of heart increased protein kinase increases Ca influx. AE: risk of angina or arrhythmias
Disopyramide
Class 1A Antiarrhythmic (Na channel blocker) Slows phase 0 depolarization in ventricular muscle fibers. Similar AE as cholinergic blocker: Dry mouth, urine retention, blurred vision, constipation
Procainamide
Class 1A Antiarrhythmic (Na channel blocker) Slows phase 0 depolarization in ventricular muscle fibers. UNIQUE: AE: lupus-like rash in 20-30% pts, some GI disturbances, CNS problems
Quinidine
Class 1A Antiarrhythmic (Na channel blocker) Slows phase 0 depolarization in ventricular muscle fibers. UNIQUE: Absorbs quickly orally, CP450 metabolized. AE: arrhythmia, GI disturbances, blurred vision. Other: increases digoxin, displaces from tissue-binding.
Lidocaine
Class 1B Antiarrhythmic (Na channel blocker) Shortens phase 3 repolarization in ventricular muscle fibers. UNIQUE: Also local anesthetic, large therapeutic index. Good for acute ventricular tachycardia and ventricular fibrillation
Mexiletine
Class 1B Antiarrhythmic (Na channel blocker) Shortens phase 3 repolarization in ventricular muscle fibers. UNIQUE: often used after MI.
Flecainide
Class 1C Antiarrhythmic (Na channel blocker) Markedly slows phase 0 depolarization in ventricular muscle fibers. AE can/does interfere with normal heart beat, Dizziness, blurred vision, HA, nausea…… slows down rise in action potential. Absorbed orally, long half-life.
Propafenone
Class 1C Antiarrhythmic (Na channel blocker) Markedly slows phase 0 depolarization in ventricular muscle fibers. AE can/does interfere with normal heart beat, Dizziness, blurred vision, HA, nausea…… slows down rise in action potential. Absorbed orally, long half-life. UNIQUE: good for atrial fibrillation
Amiodarone
Class III Antiarrhythmic (K Channel blocker) Prolongs phase 3 repolarization in ventricular muscle fibers. They prolong the AP and refractory period. AE: ventricular tachyarrhythmias. UNIQUE: shows ALL classes of actions, therapy of choice for atrial fibrillation. PHARMACOKINETICS: half life of several weeks. AE: interstitial pulmonary fibrosis, GI problems, blue skin, NAION and whorl keratopathy. good for atrial fibrillation and acute ventricular tachycardia and ventricular fibrillation
Dofetilide
Class III Antiarrhythmic (K Channel blocker) Prolongs phase 3 repolarization in ventricular muscle fibers. They prolong the AP and refractory period. AE: ventricular tachyarrhythmias. UNIQUE: risk of proarrhythmia, 6-10 hr half life, adjust dose if there is renal insufficiency. good for atrial fibrillation
Dronedarone
Class III Antiarrhythmic (K Channel blocker) Prolongs phase 3 repolarization in ventricular muscle fibers. They prolong the AP and refractory period. AE: ventricular tachyarrhythmias. UNIQUE: shorter half life, fewer side effects.
Ibutilide
Class III Antiarrhythmic (K Channel blocker) Prolongs phase 3 repolarization in ventricular muscle fibers. They prolong the AP and refractory period. AE: ventricular tachyarrhythmias. UNIQUE: risk of proarrhythmia, 6-10 hr half life, adjust dose if there is renal insufficiency.
Sotalol
Class III Antiarrhythmic (actually non-selective beta-blocker) Prolongs phase 3 repolarization in ventricular muscle fibers. Lowest rate of AE
Adenosine
Other Antiarrhythmic Drugs. MOA: activates inward K current and inhibits Ca current. This causes hyperpolarization. also inhibits AV conduction. less effective w/ caffeine. AE: flushing, SOB, chest burning. Good for acute supraventricular tachycardia.
Magnesium
Other Antiarrhythmic Drugs. MOA unknown
Potassium
Other Antiarrhythmic Drugs. proper dose balances K gradients
Abciximab
Platelet aggregation inhibitor. MOA: blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. Expensive
Aspirin
Platelet aggregation inhibitor. MOA: inhibits Cox-1. (platelet activation > arachidonic acid [Cox-1>] Prostaglandic H2 > Thromboxane A2 > clot formation). rapid effect that lasts platelet life. Tx prophylactic stroke or MI. AE: hemorrhagic stroke, GI bleeding.
Dipyridamole
Platelet aggregation inhibitor. MOA increases cAMP, which decreases Thromboxane A2 and clot formation. Very good in combination, poor alone
Eptifibatide
Platelet aggregation inhibitor. MOA blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. UNIQUE: IV only
Tirofiban
Platelet aggregation inhibitor. MOA blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. UNIQUE: IV only
Clopidogrel (Plavix)
Platelet aggregation inhibitor. MOA irreversibly blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. plasma protein bound, P450 metabolism, renal/fecal elimination. AE: prolonged bleeding, life-threatening Thrombotic thrombocytopenic purpura. UNIQUE: prodrug, can inhibit P450
Prasugrel
Platelet aggregation inhibitor. MOA irreversibly blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. plasma protein bound, P450 metabolism, renal/fecal elimination. AE: prolonged bleeding, life-threatening Thrombotic thrombocytopenic purpura. UNIQUE: prodrug, can inhibit P450
Ticagrelor
Platelet aggregation inhibitor. MOA blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. plasma protein bound, P450 metabolism, renal/fecal elimination. AE: prolonged bleeding, life-threatening Thrombotic thrombocytopenic purpura. UNIQUE: is not irreversible so it’s good for surgery
Ticlopidine
Platelet aggregation inhibitor. MOA irreversibly blocks ADP receptors, prevents fibrinogen binding to glycoprotein receptor. plasma protein bound, P450 metabolism, renal/fecal elimination. AE: prolonged bleeding, life-threatening Thrombotic thrombocytopenic purpura. UNIQUE: prodrug, can inhibit P450
Argatroban
Direct thrombin inhibitor (anticoagulant). Parenteral, liver metabolized
Bivalirudin
Direct thrombin inhibitor (anticoagulant)
Dabigatran (Pradaxa)
Direct thrombin inhibitor (anticoagulant). Prodrug. Tx prevent stroke in pts with atrial fibrillation. First oral anticoagulat since warfain. AE: bleeding